Medpace Holdings Stock News & Updates
[WKN: A2APTV | Symbol: MEDP]
Medpace Hits All-Time High – Record Orders of $873 Million Fuel Growth Story
Medpace enables small biotech companies to conduct global drug studies without their own international...
Medpace: Order Record Fuels Rally!
Industry Influence: Strong quarterly results from industry giant Danaher sparked a rally among laboratory...
These 2 Biotech Stocks Benefit From Moderna’s Breakthrough in Cancer Treatment!
The Nasdaq Biotech Index rose by +4% on Wednesday. Moderna announced a breakthrough in individualized...
Medpace: A Beneficiary of AI in Biotechnology as More Clinical Trials Launch!
Medpace is a globally operating contract research organization whose mission is to accelerate the development...
The Escalating Iran War Pushes Brent Above the $100 Mark and Sends Stocks and Bonds Down Simultaneously – Alphabet Shocks With an Investment Budget of Up to $205 Billion, Tesla Crashes 11% After the First Cash Outflow in Two Years - The 30-Year U.S. Yield Stays Above 5% for As Long As It Did Last in 2007, and Barclays Now Sees an Interest Rate Hike As the Greater Risk, While the DAX Slips Below 25,000 Points
USA & MACRO-OUTLOOK Oil prices become the dominant market driver Brent jumps by around 6.7%...
Medpace: Research Boom for Obesity Treatments Drives Growth in the Metabolic Disease Therapy Sector!
Medpace acts as a contract research organization that plans and manages clinical studies worldwide...
Stocks in Action USA: Cleveland-Cliffs, United Rentals, and Medpace.
Cleveland-Cliffs (CLF) – The US Steel Producer Benefits from Strong Domestic Demand and Looks Optimistically...
Medpace: High Order Growth in Clinical Research - Share Price Jump of 16% Towards All-Time High!
The revenue growth was 17.2% to $707.3 million in the second quarter of 2026. Net new order intake...
Medpace Holdings: Despite Record Revenue, the Order Intake Lags Behind
Medpace Holdings is a US-based contract research organization (CRO) that supports biotech, pharmaceutical,...
Analysts' Top 5 Price Targets of February 13, 2026
Deutsche Börse [DE0005810055] Barclays confirms Overweight rating and raises the price target from...
Top Breakout Candidate Medpace: Beneficiary of AI and Quantum Computers, Breaking Out from the Pivotal Base!
Among the stocks at a 52-week high in the USA, Medpace is a top breakout candidate for the remainder...